LAZERTINIB Pharmacologic Class Indexing
- Class set ID
- 116f7c1a-a488-4b90-89cb-b6cba19ce5f2
- Version
- 1
- Effective date
- 20241021
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use LAZCLUZE safely and effectively. See full prescribing information for LAZCLUZE. LAZCLUZE ® (lazertinib) tablets, for oral use Initial U.S. Approval: 2024 | Janssen Biotech, Inc. | Janssen Pharmaceutica NV | Janssen Cilag SpA | Johnson & Johnson Private Limited | Yuhan Chemical Inc. | 20260505 | 6 |